Avantor, Inc. $AVTR Holdings Reduced by New South Capital Management Inc.

New South Capital Management Inc. lowered its position in Avantor, Inc. (NYSE:AVTR) by 49.0% during the 3rd quarter, Holdings Channel.com reports. The firm owned 750,808 shares of the company’s stock after selling 721,809 shares during the quarter. New South Capital Management Inc.’s holdings in Avantor were worth $11,300,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. BlackRock Inc. acquired a new position in shares of Avantor during the second quarter worth approximately $695,784,000. Barrow Hanley Mewhinney & Strauss LLC acquired a new stake in Avantor in the 2nd quarter valued at approximately $195,386,000. Bank of America Corp DE acquired a new stake in Avantor in the 2nd quarter valued at approximately $108,795,000. Engine Capital Management LP increased its position in Avantor by 65.8% in the 1st quarter. Engine Capital Management LP now owns 19,780,830 shares of the company’s stock valued at $155,082,000 after acquiring an additional 7,853,018 shares during the period. Finally, Freestone Grove Partners LP bought a new stake in Avantor during the 2nd quarter valued at $56,577,000. Institutional investors own 95.08% of the company’s stock.

Avantor Stock Performance

Shares of NYSE AVTR opened at $15.76 on Thursday. The stock’s fifty day simple moving average is $15.68 and its 200 day simple moving average is $11.38. The stock has a market capitalization of $10.68 billion, a price-to-earnings ratio of 18.99, a PEG ratio of 7.04 and a beta of 0.95. The company has a quick ratio of 1.27, a current ratio of 1.89 and a debt-to-equity ratio of 0.63. Avantor, Inc. has a 52-week low of $7.26 and a 52-week high of $17.45.

Avantor (NYSE:AVTR) last announced its earnings results on Wednesday, October 28th. The company reported $0.22 EPS for the quarter, beating the consensus estimate of $0.21 by $0.01. Avantor had a return on equity of 9.79% and a net margin of 5.08%. The business had revenue of $1.70 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same period in the prior year, the business posted $0.22 earnings per share. Avantor’s revenue was up 4.6% compared to the same quarter last year. As a group, sell-side analysts forecast that Avantor, Inc. will post 0.82 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on AVTR shares. Deutsche Bank reiterated a “hold” rating and set a $17.00 price target on shares of Avantor in a research report on Thursday, October 29th. Royal Bank Of Canada lifted their price target on Avantor from $14.00 to $17.00 and gave the company a “sector perform” rating in a research report on Wednesday, October 28th. Stifel Nicolaus boosted their price objective on Avantor from $15.00 to $18.00 and gave the stock a “hold” rating in a research note on Thursday, October 29th. Wall Street Zen raised shares of Avantor from a “hold” rating to a “buy” rating in a report on Sunday, October 11th. Finally, Evercore set a $17.00 price target on shares of Avantor in a report on Wednesday, October 28th. Two equities research analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $14.77.

Avantor Company Profile

Avantor, Inc. is a global provider of products and services used in life sciences, advanced technology and applied materials. Its customers include biopharmaceutical and healthcare companies, laboratories, universities and manufacturers. The company supplies chemicals, reagents, laboratory consumables and equipment, as well as materials used in biopharmaceutical production. Avantor also provides services such as procurement, inventory management and support for laboratory and production operations.